Tempest Therapeutics, Inc. - Common Stock TPST 深 滬
交易中 09-20 15:15:37 美东时间
1.3905
-0.019
-1.38%
華盛通- 最 高1.44
- 今 開1.44
- 成交量 20.23万股
- 最 低 1.3604
- 昨 收 1.41
- 總市值 1852.72万
- 52周最高 9.77
- 市盈率 靜 --
- 換手率 1.52%
- 52周最低 0.17
- 委 比 -2.12%
- 總股本 1332.41万
- 歷史最高 260.10
- 量 比 0.51
- 振 幅 5.65%
- 歷史最低 0.17
- 每 手 1
- 風險率 1.35%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Tempest falls after new trial data for liver cancer therapy
Tempest Therapeutics (NASDAQ:TPST) shares dropped Thursday after the company updated data from an ongoing trial designed to test its PPAR⍺ antagonist, amezalpat (TPST-1120), as a first-line combinatio...
06-20 22:52
Market-Moving News for June 20th
HROW: 20% | Harrow shares are trading higher after the company announced the manufacture of the first of three commercial-scale process performance qualification batches of TRIESENCE 40 mg/mL. Also the company
06-20 20:17
Tempest to Participate in Upcoming Investor Conferences
BRISBANE, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (...
05-21 20:00
Tempest Therapeutics Q1 2024 GAAP EPS $(0.36) Beats $(0.37) Estimate
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.37) by 2.7 percent.
05-10 06:02
Tempest FY23 EPS $(1.91) Vs $(3.09) YoY; Ended The Year With $39.2M In Cash And Cash Equivalents
Financial Results Year End 2023 Tempest ended the year with $39.2 million in cash and cash equivalents, compared to $31.2 million on December 31, 2022. The increase was primarily due to
03-20 04:40
纳斯达克生物科技指数收跌2.53%
成分股Exscientia ADR收跌22.84%，Taysha Gene、 杰龙（GERN）、Pliant、Ovid Therapeutics、NantKw...
02-14 05:35
Jefferies Initiates Coverage On Tempest Therapeutics with Buy Rating, Announces Price Target of $15
Jefferies analyst Maury Raycroft initiates coverage on Tempest Therapeutics (NASDAQ:TPST) with a Buy rating and announces Price Target of $15.
02-08 20:46
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. ...
2023-12-02 05:15
Tempest Therapeutics shares are trading higher. The company reported Q3 financial results.
Tempest Therapeutics shares are trading higher. The company reported Q3 financi...
2023-11-10 03:04
